Treatment Options In Listeriosis
Published on: September 26, 2024
Treatment Options In Listeriosis
Article author photo

Rashmikka Bobby Rajesh

MBBS, MSc Infection, Immunity and Human Disease

Article reviewer photo

Jade Godby

BSc (Hons) Physiological Science University of Bristol. MPAS St Georges, University of London

What is listeriosis?

Listeriosis is a serious infection caused by the bacterium Listeria monocytogenes, which poses significant health risks, particularly to vulnerable populations such as pregnant women, newborns, the elderly, and immunocompromised individuals.1 Listeria is typically contracted through contaminated food products, including unpasteurized dairy products, deli meats, and certain ready-to-eat foods. Despite being relatively rare, listeriosis is a severe condition that requires prompt medical attention due to its high morbidity and mortality rates. The incidence rate is around 0.1 to 10 cases per 1 million people per year worldwide across different geographical locations.2

What are the signs and symptoms of listeriosis?

Listeriosis, caused by Listeria monocytogenes, presents a variety of symptoms depending on the individual’s age, immune status, and form of the disease. Commonly, it begins with general symptoms such as fever, muscle aches, fatigue, and malaise. Gastrointestinal symptoms, including nausea, vomiting, diarrhoea, and abdominal pain, often follow shortly after consuming contaminated food.

In pregnant women, listeriosis typically manifests as mild flu-like symptoms but can lead to severe complications such as miscarriage, stillbirth, or premature delivery. Newborns may have respiratory distress, high body temperature, poor feeding, irritability, or lethargy.

Immunocompromised individuals, such as those with HIV/AIDS, cancer, or diabetes, face more severe forms, including sepsis and meningitis. Meningitis symptoms encompass severe headaches, stiff neck, sensitivity to light, confusion, and seizures. Central nervous system involvement can lead to persistent headaches, stiff neck, confusion, convulsions, and loss of balance and coordination.

Elderly patients may show subtle symptoms like increased confusion, general weakness, fever, and chills. Clinical manifestations can include bacteraemia, with high fever and symptoms of septic shock; meningitis, with severe headache and high fever; encephalitis, presenting as fever and seizures; and endocarditis, characterized by persistent fever and heart murmurs. Early recognition and diagnosis are critical for effective treatment and management of listeriosis.

What are the risks of listeriosis?

Listeriosis can present in several forms, ranging from mild gastroenteritis to severe invasive disease affecting the central nervous system or bloodstream. The most severe form, invasive listeriosis, can lead to meningitis, septicemia, and even death if not promptly treated. The mortality rate of invasive listeriosis can be as high as 20-30%, particularly in vulnerable populations.3 The bacterium Listeria monocytogenes has a remarkable ability to survive and multiply at low temperatures, making it a formidable pathogen in refrigerated foods. Pregnant women are at ten times higher  risk than the general population of getting listeriosis. If a pregnant woman with Listeriosis is not treated, this  could lead to miscarriage, stillbirth, or preterm labour.4 Understanding the risks and potential severity of listeriosis is crucial for devising effective treatment strategies.

How can Listeriosis be diagnosed?

Early and accurate diagnosis is critical for the effective treatment of listeriosis. The diagnostic process typically involves:

  1. Clinical Evaluation: Based on symptoms such as fever, muscle aches, nausea, diarrhoea, and in severe cases, neurological symptoms like headache, stiff neck, confusion, loss of balance, or convulsions.
  2. Microbiological Testing: Blood cultures, cerebrospinal fluid (CSF) analysis, and other relevant cultures to detect Listeria monocytogenes.
  3. Molecular Methods: Polymerase chain reaction (PCR) and other molecular techniques to rapidly identify Listeria DNA in clinical samples.

What are the treatment options for listeriosis?

The treatment of listeriosis primarily involves the use of antibiotics.5 Due to the serious nature of the infection, especially in vulnerable populations such as pregnant women, newborns, the elderly, and immunocompromised individuals, prompt and effective treatment is crucial.

Antibiotic therapy

  1. First-Line Treatment
    • Ampicillin: Ampicillin is considered the antibiotic of choice for treating listeriosis.  Normally, treatment ranges from 14 to 21 days but it can depend on the severity of the infection.
    • Penicillin G: In cases where Ampicillin cannot be used, Penicillin G is administered.
  2. Combination Therapy
    • Ampicillin with Gentamicin: For severe cases, especially meningitis and bacteraemia, a combination of ampicillin and gentamicin is recommended.
  3. Alternative Antibiotics
    • Trimethoprim-Sulfamethoxazole (TMP-SMX): For patients allergic to penicillin or when first-line antibiotics are not available, TMP-SMX can be an effective alternative
    • Meropenem: In cases where Listeria is resistant to the usual antibiotics or in patients with severe allergies, meropenem can be used.
  4. Other Antibiotics
    • Erythromycin: Though not commonly used, erythromycin may be an option in certain situations.
    • Vancomycin: This antibiotic is generally reserved for cases involving severe penicillin allergies.

Special considerations

  1. Pregnant Women
    • Ampicillin: Pregnant women with listeriosis are treated with high-dose ampicillin. The treatment aims to prevent fatal infection and complications.
    • Combination Therapy: Gentamicin may be added for severe infections, but it is used cautiously due to potential risks to the foetus.
  2. Neonates
    • Ampicillin with Gentamicin: Neonates are usually treated with a combination of ampicillin and gentamicin.
    • Duration: The treatment duration is typically 14-21 days, depending on the severity of the infection.
  3. Immunocompromised Patients
    • High-Dose Antibiotics: Immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy, require high-dose intravenous antibiotics. Ampicillin, often combined with gentamicin, is used.
    • Prolonged Therapy: Due to their weakened immune systems, these patients may require a longer duration of treatment, often extending beyond 21 days.

Supportive care

  1. Hydration and Electrolytes
    • Intravenous Fluids: Patients with severe symptoms, such as those experiencing significant vomiting or diarrhea, may need intravenous fluids to maintain hydration and electrolyte balance.
    • Electrolyte Management: Monitoring and correcting electrolyte imbalances is essential, particularly in severe cases.
  2. Nutritional Support
    • Dietary Intake: Ensuring adequate nutritional intake is important, especially for pregnant women and neonates.
    • Parenteral Nutrition: In severe cases where oral intake is not possible, parenteral nutrition may be necessary.
  3. Monitoring and Follow-Up
    • Clinical Monitoring: Regular monitoring of vital signs, symptoms, and laboratory results is critical to assess the effectiveness of treatment and detect any complications early.
    • Follow-Up Cultures: Repeat blood or CSF cultures may be necessary to confirm the eradication of the infection.

Management of complications

  1. Meningitis
    • Intensive Care: Patients with listeriosis meningitis often require intensive care and close monitoring.
    • Intravenous Antibiotics: High-dose intravenous antibiotics, such as ampicillin with gentamicin, are administered for an extended duration, typically 21 days or more.
    • Corticosteroids: In some cases, corticosteroids may be used to reduce inflammation and prevent complications.
  2. Bacteraemia
    • Broad-Spectrum Antibiotics: Initial treatment with broad-spectrum antibiotics may be necessary until Listeria is confirmed, after which specific antibiotics are continued.
    • Supportive Care: Management includes supportive care for sepsis, including fluids, vasopressors, and monitoring for organ dysfunction.
  3. Endocarditis
    • Combination Therapy: Endocarditis caused by Listeria requires prolonged antibiotic therapy, often combining ampicillin and gentamicin for at least 4-6 weeks.
    • Surgical Intervention: In some cases, surgical intervention may be necessary to repair or replace damaged heart valves.
  4. Gastrointestinal Listeriosis
    • Symptomatic Treatment: Management includes rehydration and symptomatic treatment for gastrointestinal symptoms.
    • Antibiotic Therapy: Although gastrointestinal listeriosis can be self-limiting, antibiotics are used to prevent systemic spread.

Preventive measures post-treatment

  1. Food Safety Education
    • High-Risk Foods: Educating patients, especially pregnant women and immunocompromised individuals, about avoiding high-risk foods such as unpasteurized dairy products, deli meats, and certain ready-to-eat foods.
    • Proper Food Handling: Emphasizing the importance of proper food handling, storage, and preparation to reduce the risk of Listeria contamination.
  2. Regular Monitoring
    • Follow-up appointments: Scheduling regular follow-up appointments to monitor for any recurrence or late complications of the infection.
    • Routine Screening: In high-risk populations, routine screening and early treatment of any new symptoms can prevent severe outcomes.

Conclusion

Listeriosis is a serious and potentially life-threatening infection that requires prompt and effective treatment. Antimicrobial therapy, primarily with ampicillin and gentamicin, is the cornerstone of treatment, supplemented by supportive care to manage symptoms and complications. Special attention is needed for vulnerable populations, such as pregnant women, neonates, and immunocompromised individuals, to prevent severe outcomes. Preventive measures, including proper food safety practices and public health initiatives, are crucial in reducing the incidence of listeriosis. With early diagnosis, appropriate treatment, and effective prevention strategies, the impact of listeriosis can be significantly mitigated, protecting the health of at-risk populations and reducing the burden of this serious infection.

References

  1. CDC. Centers for Disease Control and Prevention. 2023 [cited 2024 Jun 8]. Frequently asked questions about listeria. Available from: https://www.cdc.gov/listeria/faq.html
  2. Listeriosis [Internet]. [cited 2024 Jun 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/listeriosis
  3. Osek J, Wieczorek K. Listeria monocytogenes—how this pathogen uses its virulence mechanisms to infect the hosts. Pathogens [Internet]. 2022 Dec 7 [cited 2024 Jun 8];11(12):1491. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783847/
  4. Khalil A, Samara A, O’Brien P, Ladhani S. Listeria outbreaks cause maternal and perinatal mortality and morbidity: we must do better. The Lancet Microbe [Internet]. 2023 Apr [cited 2024 Jun 8];4(4):e206–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2666524722003883
  5. Rogalla D, Bomar PA. Listeria monocytogenes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jun 8]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK534838/
Share

Rashmikka Bobby Rajesh

MBBS, MSc Infection, Immunity and Human Disease

I am a registered clinical doctor and a graduate of Master of Science from the University of Leeds with expertise in molecular and cellular biology. My goal is a career in high impactful research and pursue a PhD in the near future. With my research experience and personal values of scientific integrity, I aim to make a genuine contribution and meaning difference in patient lives.

arrow-right